Alphatec Wins OsseoScrew® FDA Clearance

Alphatec Holdings, Inc.  (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its OsseoScrew^® System, making it available for clinical use for the first time in the United States.

“I am exceptionally pleased that OsseoScrew has been cleared for the U.S. market,” said Pat Miles, Chairman and Chief Executive Officer. “The system will create new market opportunities for ATEC by uniquely addressing an unmet need for an underserved patient population.  We are building an organic innovation machine and today’s announcement represents another significant step toward creating a clinically distinguished portfolio.”

https://www.marketscreener.com/ALPHATEC-HOLDINGS-INC-30652876/news/Alphatec-Advances-Clinical-Distinction-With-OsseoScrew-Clearance-27322251/